Payment overview · 2025
General Payments
$233.40
11 reported records · 5 companies
Healthcare provider profile · identity verified
James W Mcdowell, MD
Allopathic & Osteopathic Physicians|Family Medicine · MACON, MO · NPI 1255370482
Verified facts
What the public records show
CMS Open Payments records show James W Mcdowell, MD received $233.40 in general payments during 2025 across 11 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 50.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 10 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Abrysvo.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Linzess by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABRYSVO as an associated drug or biological on 55380 records involving 31565 distinct recipient NPIs. Public Medicare Part D data also shows 103 claims for Abrysvo by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 435 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 33 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $118.53 | 50.8% | 6 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $61.03 | 26.1% | 2 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $19.63 | 8.4% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $18.06 | 7.7% | 1 | 2025 |
| Integra LifeSciences Corporation | Unresolved — no canonical attribution shown | $16.15 | 6.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $218.77 | 10 |
| Education | $14.63 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $118.53 | 6 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $61.03 | 2 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $30.74 | 1 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $19.63 | 1 | 2025 |
Source payment records
|
|||||
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $18.06 | 1 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $18.06 | 1 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $18.06 | 1 | 2025 |
Source payment records
|
|||||
| Integra Normalized: integra |
Device | Integra LifeSciences Corporation | $16.15 | 1 | 2025 |
Source payment records
|
|||||
| Integra Dermal Regeneration Template Normalized: integra dermal regeneration template |
Device | Integra LifeSciences Corporation | $16.15 | 1 | 2025 |
Source payment records
|
|||||
| PRIMATRIX Normalized: primatrix |
Device | Integra LifeSciences Corporation | $16.15 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ABRYSVO abrysvo |
2025 | Abrysvo | 2024 | 103 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ABRYSVO open payments reported associated product |
CMS Open Payments — General Payments 55380 supporting records · 31565 recipient NPIs · example record 1228794147 |
Abrysvo · 2024 Exact normalized brand match · 1 Part D row |
103 | 103 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
435 | 43 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
33 | 33 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1084 | 176 |
| Atorvastatin Calcium | Atorvastatin Calcium | 908 | 202 |
| Amlodipine Besylate | Amlodipine Besylate | 631 | 135 |
| Lisinopril | Lisinopril | 597 | 132 |
| Sertraline Hcl | Sertraline Hcl | 554 | 84 |
| Gabapentin | Gabapentin | 531 | 101 |
| Losartan Potassium | Losartan Potassium | 503 | 109 |
| Omeprazole | Omeprazole | 493 | 109 |
| Furosemide | Furosemide | 453 | 78 |
| Eliquis | Apixaban | 435 | 43 |
| Pantoprazole Sodium | Pantoprazole Sodium | 385 | 84 |
| Potassium Chloride | Potassium Chloride | 374 | 70 |
| Metformin Hcl | Metformin Hcl | 368 | 77 |
| Tamsulosin Hcl | Tamsulosin Hcl | 346 | 61 |
| Metoprolol Tartrate | Metoprolol Tartrate | 315 | 59 |
| Metoprolol Succinate | Metoprolol Succinate | 294 | 58 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 279 | 60 |
| Donepezil Hcl | Donepezil Hcl | 262 | 35 |
| Hydrochlorothiazide | Hydrochlorothiazide | 242 | 62 |
| Trazodone Hcl | Trazodone Hcl | 235 | 41 |
| Glimepiride | Glimepiride | 203 | 46 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 201 | 64 |
| Finasteride | Finasteride | 193 | 31 |
| Tramadol Hcl | Tramadol Hcl | 191 | 43 |
| Montelukast Sodium | Montelukast Sodium | 185 | 38 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 184 | 40 |
| Carvedilol | Carvedilol | 182 | 42 |
| Escitalopram Oxalate | Escitalopram Oxalate | 175 | 27 |
| Allopurinol | Allopurinol | 169 | 38 |
| Meloxicam | Meloxicam | 169 | 42 |
| Fluticasone Propionate | Fluticasone Propionate | 156 | 39 |
| Clopidogrel | Clopidogrel Bisulfate | 155 | 30 |
| Duloxetine Hcl | Duloxetine Hcl | 155 | 33 |
| Fluoxetine Hcl | Fluoxetine Hcl | 151 | 18 |
| Memantine Hcl | Memantine Hcl | 149 | 18 |
| Buspirone Hcl | Buspirone Hcl | 139 | 17 |
| Famotidine | Famotidine | 139 | 30 |
| Simvastatin | Simvastatin | 138 | 30 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 133 | 17 |
| Metformin Hcl Er | Metformin Hcl | 125 | 25 |
| Alprazolam | Alprazolam | 122 | 20 |
| Spironolactone | Spironolactone | 121 | 26 |
| Divalproex Sodium | Divalproex Sodium | 120 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 114 | 16 |
| Lovastatin | Lovastatin | 108 | 25 |
| Pravastatin Sodium | Pravastatin Sodium | 107 | 27 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 103 | 103 |
| Mirtazapine | Mirtazapine | 101 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 100 | 15 |
| Cephalexin | Cephalexin | 96 | 59 |
| Lorazepam | Lorazepam | 95 | 29 |
| Alendronate Sodium | Alendronate Sodium | 94 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 91 | 17 |
| Clonazepam | Clonazepam | 90 | 12 |
| Atenolol | Atenolol | 88 | 14 |
| Pregabalin | Pregabalin | 84 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 83 | 24 |
| Ozempic | Semaglutide | 83 | 20 |
| Baclofen | Baclofen | 77 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 74 | 13 |
| Myrbetriq | Mirabegron | 72 | suppressed |
| Gemtesa | Vibegron | 71 | suppressed |
| Bupropion Xl | Bupropion Hcl | 69 | 12 |
| Pioglitazone Hcl | Pioglitazone Hcl | 69 | 16 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 68 | suppressed |
| Levetiracetam | Levetiracetam | 67 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 62 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 62 | 13 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 62 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 61 | suppressed |
| Ketoconazole | Ketoconazole | 60 | 16 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 59 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 58 | 14 |
| Olanzapine | Olanzapine | 58 | suppressed |
| Aripiprazole | Aripiprazole | 57 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 57 | 15 |
| Torsemide | Torsemide | 57 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 56 | 12 |
| Warfarin Sodium | Warfarin Sodium | 56 | 11 |
| Topiramate | Topiramate | 55 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 54 | 39 |
| Diclofenac Sodium | Diclofenac Sodium | 53 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 52 | 26 |
| Farxiga | Dapagliflozin Propanediol | 51 | suppressed |
| Admelog Solostar | Insulin Lispro | 50 | suppressed |
| Prednisone | Prednisone | 49 | 18 |
| Ventolin Hfa | Albuterol Sulfate | 49 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 49 | 12 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 45 | 45 |
| Nifedipine Er | Nifedipine | 44 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 44 | 13 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 43 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 43 | 27 |
| Bupropion Hcl Sr | Bupropion Hcl | 42 | suppressed |
| Irbesartan | Irbesartan | 42 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 41 | suppressed |
| Risperidone | Risperidone | 41 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 41 | suppressed |
| Verapamil Sr | Verapamil Hcl | 41 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 40 | suppressed |
| Celecoxib | Celecoxib | 40 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 40 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 40 | suppressed |
| Nystatin | Nystatin | 40 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 40 | suppressed |
| Cilostazol | Cilostazol | 39 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 38 | 33 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 37 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 37 | suppressed |
| Glipizide | Glipizide | 36 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 36 | 23 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 35 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 35 | 27 |
| Januvia | Sitagliptin Phosphate | 35 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 35 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 34 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 34 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 34 | 14 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 34 | suppressed |
| Asenapine Maleate | Asenapine Maleate | 33 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 33 | 33 |
| Diazepam | Diazepam | 32 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 32 | suppressed |
| Jardiance | Empagliflozin | 32 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 31 | suppressed |
| Sucralfate | Sucralfate | 31 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 30 | suppressed |
| Clotrimazole | Clotrimazole | 29 | suppressed |
| Digoxin | Digoxin | 29 | suppressed |
| Estradiol | Estradiol | 29 | suppressed |
| Trulicity | Dulaglutide | 29 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 28 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 28 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 28 | suppressed |
| Mounjaro | Tirzepatide | 28 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 12 |
| Benazepril Hcl | Benazepril Hcl | 27 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 27 | suppressed |
| Colchicine | Colchicine | 27 | 12 |
| Ondansetron Odt | Ondansetron | 27 | 16 |
| Spiriva Respimat | Tiotropium Bromide | 27 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 26 | suppressed |
| Glipizide Er | Glipizide | 26 | suppressed |
| Nystop | Nystatin | 26 | 15 |
| Xarelto | Rivaroxaban | 26 | suppressed |
| Azithromycin | Azithromycin | 25 | 20 |
| Lansoprazole | Lansoprazole | 25 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 25 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 25 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 24 | suppressed |
| Nyamyc | Nystatin | 24 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 24 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 24 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 23 | suppressed |
| Ezetimibe | Ezetimibe | 23 | suppressed |
| Methocarbamol | Methocarbamol | 23 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 23 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 22 | 18 |
| Klor-Con M20 | Potassium Chloride | 22 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 22 | 11 |
| Risperidone Odt | Risperidone | 22 | suppressed |
| Fluconazole | Fluconazole | 21 | 11 |
| Ipratropium Bromide | Ipratropium Bromide | 21 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 21 | suppressed |
| Trospium Chloride | Trospium Chloride | 21 | suppressed |
| Bumetanide | Bumetanide | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Amoxicillin | Amoxicillin | 19 | 13 |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 19 | 19 |
| Arnuity Ellipta | Fluticasone Furoate | 18 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 18 | suppressed |
| Chlorthalidone | Chlorthalidone | 18 | suppressed |
| Etodolac | Etodolac | 18 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 18 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 18 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 18 | suppressed |
| Verapamil Er | Verapamil Hcl | 18 | suppressed |
| Calcitriol | Calcitriol | 17 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 17 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 17 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 17 | suppressed |
| Rivastigmine | Rivastigmine | 17 | suppressed |
| Febuxostat | Febuxostat | 16 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 16 | suppressed |
| Klor-Con M10 | Potassium Chloride | 16 | suppressed |
| Temazepam | Temazepam | 16 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 16 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 15 | suppressed |
| Amantadine | Amantadine Hcl | 15 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 15 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 15 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 15 | suppressed |
| Nabumetone | Nabumetone | 15 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Haloperidol | Haloperidol | 14 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Latanoprost | Latanoprost | 14 | suppressed |
| Lubiprostone | Lubiprostone | 14 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 14 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 14 | suppressed |
| Belsomra | Suvorexant | 13 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 13 | suppressed |
| Desipramine Hcl | Desipramine Hcl | 13 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 13 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 13 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 13 | suppressed |
| Telmisartan | Telmisartan | 13 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 12 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Paroxetine Er | Paroxetine Hcl | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Methadone Hcl | Methadone Hcl | 11 | suppressed |
| Metolazone | Metolazone | 11 | suppressed |
| Naproxen | Naproxen | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Tradjenta | Linagliptin | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $233.40 · 11 records | Otsuka America Pharmaceutical, Inc. | ABRYSVO, COMIRNATY, INGREZZA, Integra, Integra Dermal Regeneration Template, PREVNAR 20, PRIMATRIX, QULIPTA, REXULTI, UBRELVY | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Abrysvo play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error